Abstract
An important objective of brain tumor modeling is to predict the progression of tumors so as to provide guidance about the best possible medical treatment to halt or slow the tumors growth. Such computer models also provide a deeper insight into the physiology of tumors. In addition, one can study various what-if scenarios, for instance, investigating the response of tumors following the administration of a drug or a variety of drugs. Abrupt changes in growth rate can also be important for surgical decision-making. Despite increased interest in modeling techniques, relatively little progress has been made in improving such technologies. One problem is the limited data available from patients, typically 1 to 3 MRI (magnetic resonance imaging) sessions, from which one has to extrapolate the type of tumor so as to successfully predict its evolution over time. Here, the biological and clinical aspects of tumor growth and treatment with surgery, radiotherapy and drugs are discussed in the light of a patient with a brain tumor showing accelerated growth over time. Then, the contributions of mathematical modeling of tumor growth and effects of treatment are presented. Current tumor growth models can be roughly divided in three main categories, (i) cellular and microscopic models that emphasize isolated cell behavior, (ii) macroscopic models that concentrate on the development of cell density over time, and (iii) hybrid approaches that contain elements of both microscopic and macroscopic models. The mathematical theory that underlies these simulation methods is remarkably similar to the physical theory that forms the basis of protein modeling and molecular mechanics tools. A severe limitation of current models is that they are in fact not patient-specific at all.
Mini-Reviews in Medicinal Chemistry
Title: Computer Modeling of Brain Tumor Growth
Volume: 8 Issue: 14
Author(s): Andre H. Juffer, U. Marin, O. Niemitalo and J. Koivukangas
Affiliation:
Abstract: An important objective of brain tumor modeling is to predict the progression of tumors so as to provide guidance about the best possible medical treatment to halt or slow the tumors growth. Such computer models also provide a deeper insight into the physiology of tumors. In addition, one can study various what-if scenarios, for instance, investigating the response of tumors following the administration of a drug or a variety of drugs. Abrupt changes in growth rate can also be important for surgical decision-making. Despite increased interest in modeling techniques, relatively little progress has been made in improving such technologies. One problem is the limited data available from patients, typically 1 to 3 MRI (magnetic resonance imaging) sessions, from which one has to extrapolate the type of tumor so as to successfully predict its evolution over time. Here, the biological and clinical aspects of tumor growth and treatment with surgery, radiotherapy and drugs are discussed in the light of a patient with a brain tumor showing accelerated growth over time. Then, the contributions of mathematical modeling of tumor growth and effects of treatment are presented. Current tumor growth models can be roughly divided in three main categories, (i) cellular and microscopic models that emphasize isolated cell behavior, (ii) macroscopic models that concentrate on the development of cell density over time, and (iii) hybrid approaches that contain elements of both microscopic and macroscopic models. The mathematical theory that underlies these simulation methods is remarkably similar to the physical theory that forms the basis of protein modeling and molecular mechanics tools. A severe limitation of current models is that they are in fact not patient-specific at all.
Export Options
About this article
Cite this article as:
Juffer H. Andre, Marin U., Niemitalo O. and Koivukangas J., Computer Modeling of Brain Tumor Growth, Mini-Reviews in Medicinal Chemistry 2008; 8 (14) . https://dx.doi.org/10.2174/138955708786786471
DOI https://dx.doi.org/10.2174/138955708786786471 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Imaging Reporters and Multimodal Molecular Bio-Imaging: A Database of Available Probes for Multi-Modality Bio-Imaging of Reporter Gene Expression
Recent Patents on Medical Imaging Ozone Dosage Effect on C6 Cell Growth: in Vitro and in Vivo Tests
Anti-Cancer Agents in Medicinal Chemistry Cancer Drug Discovery Targeting Histone Methyltransferases: An Update
Current Medicinal Chemistry Antisense Strategies in Therapy of Gliomas
Current Signal Transduction Therapy Neovascular Age-related Macular Degeneration: Past, Present, and Future
Current Angiogenesis (Discontinued) Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis
Current Cancer Drug Targets EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo
Current Cancer Drug Targets A Review of Nanocarrier-Based CNS Delivery Systems
Current Drug Delivery Editorial [Hot topic: Current Formulations and Techniques of Drug/gene Delivery for Targeted Therapy and Tissue Engineering (Executive Editors: Chi-Hwa Wang and Sudhir H. Ranganath)]
Current Pharmaceutical Design Intraoperative Targeted Optical Imaging: A Guide towards Tumor-Free Margins in Cancer Surgery
Current Pharmaceutical Biotechnology Chemoradiation for Glioblastoma
Current Drug Therapy Phosphoinositide 3-Kinases and Leukocyte Migration
Current Immunology Reviews (Discontinued) Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Antineoplastic Chemotherapy Induced QTc Prolongation
Current Drug Safety Potentials of ES Cell Therapy in Neurodegenerative Diseases
Current Pharmaceutical Design Mesenchymal Stem Cells for Anti-Cancer Drug Delivery
Recent Patents on Anti-Cancer Drug Discovery Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs
Current Medicinal Chemistry Genetic and Epigenetic Studies for Determining Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets Risk Assessment of the Use of Autonomous Parvovirus-Based Vectors
Current Gene Therapy Human Apurinic/Apyrimidinic Endonuclease (APE1): An Emerging Anti-Cancer Biomarker
Recent Patents on Biomarkers